News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
374,099 Results
Type
Article (45001)
Company Profile (33)
Press Release (329065)
Multimedia
Podcasts (67)
Webinars (10)
Section
Business (105253)
Career Advice (1775)
Deals (13113)
Drug Delivery (71)
Drug Development (43663)
Employer Resources (118)
FDA (8519)
Job Trends (8529)
News (173781)
Policy (16895)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2024 Pharm Country Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
Academia (2773)
Academic (1)
Accelerated approval (4)
Adcomms (15)
Allergies (45)
Alliances (25536)
ALS (60)
Alzheimer's disease (902)
Antibody-drug conjugate (ADC) (57)
Approvals (8559)
Artificial intelligence (142)
Autoimmune disease (12)
Automation (8)
Bankruptcy (143)
Best Places to Work (7212)
BIOSECURE Act (16)
Biosimilars (43)
Biotechnology (29)
Bladder cancer (40)
Brain cancer (17)
Breast cancer (153)
Cancer (1287)
Cardiovascular disease (87)
Career advice (1478)
Career pathing (22)
CAR-T (75)
Cell therapy (221)
Cervical cancer (15)
Clinical research (34411)
Collaboration (374)
Compensation (75)
Complete response letters (6)
COVID-19 (1986)
CRISPR (20)
C-suite (202)
Cystic fibrosis (56)
Data (1270)
Decentralized trials (2)
Denatured (27)
Depression (23)
Diabetes (146)
Diagnostics (4029)
Digital health (13)
Diversity (9)
Diversity, equity & inclusion (31)
Drug discovery (59)
Drug pricing (84)
Drug shortages (13)
Duchenne muscular dystrophy (50)
Earnings (26595)
Editorial (35)
Employer branding (12)
Employer resources (99)
Events (47552)
Executive appointments (622)
FDA (9230)
Featured Employer (12)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (410)
Gene editing (50)
Generative AI (12)
Gene therapy (159)
GLP-1 (375)
Government (3534)
Grass and pollen (2)
Guidances (23)
Healthcare (12326)
Huntington's disease (7)
IgA nephropathy (16)
Immunology and inflammation (46)
Indications (16)
Infectious disease (2081)
Inflammatory bowel disease (62)
Inflation Reduction Act (5)
Influenza (30)
Intellectual property (39)
Interviews (322)
IPO (5999)
IRA (32)
Job creations (1551)
Job search strategy (1261)
Kidney cancer (8)
Labor market (22)
Layoffs (171)
Leadership (10)
Legal (3498)
Liver cancer (33)
Lung cancer (200)
Lymphoma (98)
Machine learning (5)
Management (43)
Manufacturing (125)
MASH (37)
Medical device (7151)
Medtech (7153)
Mergers & acquisitions (7257)
Metabolic disorders (336)
Multiple sclerosis (37)
NASH (11)
Neurodegenerative disease (52)
Neuropsychiatric disorders (15)
Neuroscience (1195)
NextGen: Class of 2025 (4671)
Non-profit (4045)
Northern California (1302)
Now hiring (30)
Obesity (157)
Opinion (148)
Ovarian cancer (49)
Pain (60)
Pancreatic cancer (43)
Parkinson's disease (76)
Partnered (12)
Patents (100)
Patient recruitment (60)
Peanut (27)
People (46383)
Pharmaceutical (5)
Pharmacy benefit managers (12)
Phase I (10342)
Phase II (15170)
Phase III (11590)
Pipeline (564)
Policy (118)
Postmarket research (1600)
Preclinical (5181)
Press Release (31)
Prostate cancer (70)
Psychedelics (20)
Radiopharmaceuticals (141)
Rare diseases (195)
Real estate (2940)
Recruiting (47)
Regulatory (11133)
Reports (22)
Research institute (2074)
Resumes & cover letters (280)
Rett syndrome (3)
RNA editing (2)
RSV (30)
Schizophrenia (48)
Series A (60)
Series B (40)
Sickle cell disease (28)
Southern California (980)
Special edition (5)
Spinal muscular atrophy (100)
Sponsored (18)
Startups (2000)
State (1)
Stomach cancer (3)
Supply chain (30)
Tariffs (23)
The Weekly (38)
United States (10838)
Vaccines (463)
Venture capitalists (16)
Weight loss (118)
Women's health (22)
Worklife (11)
Date
Today (88)
Last 7 days (274)
Last 30 days (1278)
Last 365 days (16358)
2025 (4751)
2024 (17530)
2023 (20558)
2022 (27260)
2021 (30792)
2020 (31933)
2019 (29726)
2018 (22354)
2017 (17747)
2016 (17999)
2015 (20533)
2014 (15479)
2013 (14107)
2012 (14725)
2011 (14982)
2010 (13208)
Location
Africa (616)
Alabama (24)
Alaska (5)
Arizona (101)
Arkansas (13)
Asia (21900)
Australia (4113)
California (2758)
Canada (931)
China (293)
Colorado (132)
Connecticut (133)
Delaware (70)
Europe (50601)
Florida (416)
Georgia (103)
Idaho (31)
Illinois (294)
India (13)
Indiana (152)
Iowa (4)
Japan (89)
Kansas (43)
Kentucky (18)
Louisiana (5)
Maine (23)
Maryland (575)
Massachusetts (1870)
Michigan (103)
Minnesota (176)
Mississippi (2)
Missouri (61)
Montana (12)
Nebraska (12)
Nevada (41)
New Hampshire (42)
New Jersey (921)
New Mexico (16)
New York (806)
North Carolina (501)
North Dakota (5)
Northern California (1302)
Ohio (120)
Oklahoma (8)
Oregon (14)
Pennsylvania (573)
Puerto Rico (3)
Rhode Island (22)
South America (687)
South Carolina (10)
South Dakota (1)
Southern California (980)
Tennessee (49)
Texas (453)
Utah (76)
Virginia (76)
Washington D.C. (44)
Washington State (270)
West Virginia (2)
Wisconsin (33)
374,099 Results for "national sun yat sen university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
Biotech Leaders Implore Sen. Cassidy To Step Up in Wake of FDA Cuts
Biotech companies are already seeing regulatory delays and plenty of uncertainty after around 3,500 FDA employees were cut by the Trump administration.
April 10, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Sun Pharma to Acquire Checkpoint Therapeutics
March 10, 2025
·
24 min read
Pharm Country
Sen-Jam Pharmaceutical Completes Enrollment for Phase 2 Upper Respiratory Infection/COVID Therapeutic
Sen-Jam Pharmaceutical is pleased to announce the successful completion of participant enrollment for the clinical trial of its innovative therapeutic, SJP-002C in partnership with Duke University.
June 24, 2024
·
3 min read
InnoCare Announces First Pediatric Patient Dosed in Clinical Trial of pan-TRK Inhibitor Zurletrectinib in China
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first pediatric patient has been dosed in clinical trial with its second generation pan-TRK inhibitor zurletrectinib at Sun Yat-sen University Cancer Center.
January 23, 2024
·
2 min read
Drug Development
Chipscreen NewWay: First Patient Dosed in Phase 1 Trial of the Bispecific Antibody NWY001, a Next-generation Tumor Immunotherapy in Patients with Advanced Solid Tumors
Chengdu Chipscreen NewWay Biosciences Co., Ltd. announced that on January 5, 2024, the dosing of the first patient for a phase I clinical trial of a PD-1/CD40 bispecific antibody, NWY001, at Sun Yat-Sen University Cancer Center in China, the trial-leading institution.
January 16, 2024
·
5 min read
Press Releases
Sun Pharma and Moebius Medical Announce Dual Publications on MM-II’s Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage
April 24, 2025
·
5 min read
Press Releases
Sensorion Announces the End of Patient Inclusion in NOTOXIS Phase 2a Clinical Trial of SENS-401 for the Prevention of Cisplatin-Induced Ototoxicity
March 7, 2025
·
6 min read
Press Releases
Sensorion Receives Positive Recommendation from Data Monitoring Committee of SENS-501’s Audiogene Phase 1/2 Clinical Trial
February 21, 2025
·
6 min read
Deals
Sun Pharma Completes Taro Merger
Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) with its subsidiary.
June 24, 2024
·
1 min read
Deals
Taro Shareholders Approve Merger with Sun Pharma
Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. announced that the merger agreement between Taro and Sun Pharma was approved by the affirmative vote of Taro shareholders at an Extraordinary General Meeting and an Ordinary Class Meeting on May 22, 2024.
May 23, 2024
·
4 min read
1 of 37,410
Next
